Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder

Objectives: It is estimated that 30–40% of adolescents with major depressive disorder (MDD) do not receive full benefit from current antidepressant therapies. Repetitive transcranial magnetic stimulation (rTMS) is a novel therapy approved by the US Food and Drug Administration to treat adults with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wall, Christopher A., Croarkin, Paul E., McClintock, Shawn M., Murphy, Lauren L., Bandel, Lorelei A., Sim, Leslie A., Sampson, Shirlene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859914/
https://www.ncbi.nlm.nih.gov/pubmed/24376426
http://dx.doi.org/10.3389/fpsyt.2013.00165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859914/
https://www.ncbi.nlm.nih.gov/pubmed/24376426
http://dx.doi.org/10.3389/fpsyt.2013.00165

Ejemplares similares